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Background: Follow up of Human Immunodeficiency Virus (HIV)-exposed infants is an important component of
Prevention of Mother-to-Child Transmission (PMTCT) programmes in order to ascertain infant outcomes post
delivery. We determined HIV transmission, mortality and loss to follow-up (LTFU) of HIV-exposed infants attending
a postnatal clinic in an urban hospital in Durban, South Africa.
Methods: We conducted a retrospective cohort study of infants born to women in the PMTCT programme at
McCord Hospital, where mothers paid a fee for service. Data were abstracted from patient records for live-born
infants delivered between 1 May 2008 and 31 May 2009. The infants’ LTFU status and age was based on the date
of the last visit. HIV transmission was calculated as a proportion of infants followed and tested at six weeks.
Mortality rates were analyzed using Kaplan-Meier (K-M), with censoring on 15 January 2010, LTFU or death.
Results: Of 260 infants, 155 (59.6%) remained in care at McCord beyond 28 weeks: one died at < 28 days, three
died between one to six months; 34 were LTFU within seven days, 60 were LTFU by six months. K-M mortality rate:
1.7% at six months (95% confidence interval (CI): 0.6% to 4.3%). Of 220 (83%) infants tested for HIV at six weeks,
six (2.7%, 95% CI: 1.1% to 5.8%) were HIV-infected. In Cox regression analysis, late antenatal attendance (≥ 28 weeks
gestation) relative to attending in the first trimester was a predictor for infant LTFU (adjusted hazards ratio = 2.3;
95% CI: 1.0 to 5.1; p = 0.044).
Conclusion: This urban PMTCT programme achieved low transmission rates at six weeks, but LTFU in the first
six months limited our ability to examine HIV transmission up to 18 months and determinants of mortality.
The LTFU of infants born to women who attended antenatal care at 28 weeks gestation or later emphasizes
the need to identify late antenatal attendees for follow up care to educate and support them regarding the
importance of follow up care for themselves and their infants.
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Globally, approximately 370 000 children were newly
infected with Human Immunodeficiency Virus (HIV)
in 2009; the vast majority in sub-Saharan Africa [1],
mostly due to mother-to-child transmission. In resource-
constrained settings, with little or no antiretroviral treat-
ment, approximately one-third of HIV-infected children
die before one year and more than half die before two
years of age [2]. In South Africa (SA), where the 2008
antenatal HIV seroprevalence was 29% [3], the child
mortality rate increased from 56 per 1000 live births
in 1990 to 67 per 1000 in 2008 [4]; HIV was the main
contributor to the rising child mortality, responsible for
approximately 40% of under-five mortality in 2000 [5].
Between 2001 and 2006, in a rural area of northern
KwaZulu-Natal, improving maternal access to antiretro-
viral therapy (ART) and Prevention of Mother-to-Child
Transmission (PMTCT) interventions resulted in a 57%
decline in infant mortality [6].
While PMTCT interventions in SA prior to 2010 fo-
cused only on the perinatal period [7], the updated
guidelines now recommend continuing ART during the
postnatal period while breastfeeding and the use of oral
nevirapine for all infants born to HIV-infected women
who are not on ART for life and still breastfeeding (until
one week after cessation of breastfeeding) [8]. With the
successful implementation of the current South African
antenatal PMTCT programmes aiming to reduce vertical
transmission of HIV to less than five percent [9], poor
follow-up of HIV-exposed infants remains a major
weakness, undermining the ability to support safe infant
feeding practices and to measure infant HIV-free sur-
vival at 18 months. Hence, understanding the determi-
nants of retention is important. In a public-funded
urban hospital in Johannesburg, South Africa, almost
half of infants born to HIV-infected mothers in a routine
PMTCT service were lost to follow-up (LTFU) by two
weeks of age [10]. At the time this study was conducted,
the national guidelines in South Africa did not include
routine HIV testing for infants at six weeks and recom-
mended testing for infants at 12 months of age [10].
Similarly, studies from Zimbabwe, Uganda, and Malawi
reported LTFU of infants born to HIV-infected mothers
in PMTCT programmes of 41% at 12 months, 30% at
18 months, and 30% at 24 months, respectively [11-13].
In a hospital in Malawi 88% of infants who received
nevirapine at the hospital were seen at the postnatal
clinic [14]. More than half of these infants (n = 122, 54%)
returned for their six month follow-up visit [14]. Early
recognition of HIV-exposed infants is crucial given the
higher incidence of infectious disease morbidity and
mortality observed in HIV-infected and uninfected
infants [2,15-18]. Further, early identification of HIV-
infected infants is essential for initiation of ART, whichcan reduce early infant mortality by 76% and HIV dis-
ease progression by 75% [19].
In response to an increasing concern about LTFU of
infants born to HIV-infected women in the PMTCT
programme following delivery, in May 2008, McCord
Hospital implemented a postnatal clinic for all HIV-
infected mothers (with their infants) who had attended
the PMTCT programme at the hospital. This new postna-
tal service provided an opportunity to characterize the fre-
quency and correlates of LTFU of infants born to women
attending the PMTCT programme at McCord Hospital.
Methods
Design and setting
We conducted a retrospective cohort study of infants
born to HIV-infected women attending McCord Hos-
pital, a state-subsidized hospital in Durban, which serves
a population from a wide geographic catchment area.
The patient population attending the hospital is pre-
dominantly a lower-middle-income, medically uninsured
population. All postnatal services for HIV-exposed
infants are free but the mothers receiving care paid a
user fee of ZAR 160 (~$US24) per visit at the time.
The study population consisted of infants born to
HIV-infected women who received antiretroviral pro-
phylaxis or ART from the McCord Hospital PMTCT
programme, and whose infants were born at the hospital
or elsewhere between 1 May 2008 and 31 May 2009,
and/or whose infants were presented for care following
delivery to McCord Hospital.
PMTCT care at McCord Hospital
In February 2008, the South African Department of
Health (DoH) adopted a new PMTCT protocol, which
was more aligned to the World Health Organization
2006 recommendations [7,20]. The main change to
the national protocol was the addition of short course
zidovudine from 28 weeks gestation, to the single dose
(sd)-nevirapine at delivery for all pregnant women with
CD4+ cell counts above 200 cells/mm3.
The PMTCT guidelines used at McCord Hospital,
before the updated DoH guidelines were based on evi-
dence from international studies [21,22]. Pregnant
women with CD4+ cell counts above 200 cells/mm3 were
initiated on prophylactic antiretroviral regimens, chosen
according to the maternal viral load and the gestational
age at first visit [21,22]. HIV-infected pregnant women
were offered an elective caesarean section if their viral
load was above 1000 copies/ml at 36 weeks (Giddy, J.
Personal communication, June 2008). For women who
did not attend antenatal services prior to delivery and
were not receiving antiretroviral prophylaxis or therapy,
the 2008 McCord Hospital guidelines were as follows:
intrapartum sd-nevirapine with a postpartum seven day
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were amended to include three-hourly intrapartum zido-
vudine. Infants received sd-nevirapine within 72 hours
of delivery. Newborn infants were given four weeks
zidovudine postpartum for the following reasons: (i) if the
mother received no ART during pregnancy; (ii) if
the maternal viral load was above 1000 copies/ml at
36 weeks gestation; or (iii) if the mother had received less
than one month of ART prior to delivery. Those infants
whose mothers received more than four weeks of ART
antenatally were given zidovudine for one week post par-
tum. All women received antenatal counselling regarding
infant feeding options, and were supported in their choice.
In April 2010, the National PMTCT guidelines were
revised to include triple ART for life for women with a
CD4+ cell count of 350 cells/mm3 or less; or zidovudine
from 14 weeks of pregnancy, intrapartum (sd)-nevirapine
and three-hourly zidovudine, and a postpartum tail of
sd-tenofovir and emtracitabine for women with a CD4+
cell count more than 350 cells/mm3 [8]. The 2010 guide-
line on infant antiretroviral prophylaxis included six
weeks of infant nevirapine for the non-breastfed
infant or if the breastfeeding mother was receiving life-
long ART [8]. In breastfed infants, oral nevirapine was
provided for the duration of breastfeeding until one
week after cessation of breastfeeding [8].
Patient visits
At McCord Hospital, HIV-infected pregnant women
have a baseline CD4+ cell count and viral load investi-
gations at their initial presentation for antenatal care. At
each visit, women receive a comprehensive consultation
that includes tuberculosis screening. The postnatal clinic
provides the following care up to 18 months post deliv-
ery: maternal HIV care and ART provision, infant HIV
testing at six weeks by polymerase chain reaction (PCR)
and 18 month HIV antibody testing, primary health
care for the mother and infant, which includes immu-
nization, development and growth monitoring, reproduct-
ive health care, psychosocial support, and appropriate
health promotion. Socio-demographic, biologic, clinical
and immunologic data on mothers and their infants are
recorded on standard clinic forms.
Infant HIV infection status is determined by PCR on
dried blood spots (DBS Sample Collection Kit for Infant
HIV PCR Tests – CCMT Programme, Lasec, SA) col-
lected from heel prick at six weeks of age. A subsequent
HIV PCR is collected at 14 weeks of age. For breastfed
infants, an additional PCR assay is performed six weeks
after cessation of breastfeeding. Infants who test negative
for HIV at 14 weeks of age at the postnatal clinic are
offered a rapid HIV test at 18 months using a Determine
HIV 1/2 Test Abbott Laboratories, Abbott Park, IL and
Sensa Tri-Line HIV 1/2/0 (Hitech Healthcare LTD,China). An infant was presumed HIV-1 uninfected if
they had negative DNA PCR assays at six and 14 weeks
of age. A child was classified as HIV-1 uninfected if both
antibody tests were negative at or after 18 months.
For all patients who do not return for follow-up visit,
three different attempts are made to contact the patient
by phone. Reasons for not returning for care are docu-
mented when provided.
Data collection
Routine data on antenatal history, care, treatment and
delivery were collected from maternal antenatal and
PMTCT records. Data were abstracted to a specific
study data collection form and then entered into a data-
base by a trained data capturer.
LTFU outcome
Data on the infants’ follow-up care were obtained from
their records. The infants’ LTFU status and age was
assigned based on the date of their last clinic visit.
Infants who missed a scheduled visit but subsequently
presented for a consultation (either scheduled or un-
scheduled) to McCord Hospital were not considered lost
to follow-up. Initial follow-up periods occurred at one,
six, ten, and 14 weeks; but later changed to six, nine, 12,
15 and 18 months to coincide with the South African
immunization schedule. A LTFU status was assigned if
the infant did not return within two weeks of scheduled
visits in the first five months or within one month of the
later follow-up visits. Infants who were referred to other
clinics or discharged or transferred from the clinic at
18 months were not considered LTFU.
Mortality
The neonatal mortality rate is defined as the number of
deaths in the first 28 completed days of life per 1000 live
births in a given year or period and the perinatal mortal-
ity rate is defined as the number of stillbirths and deaths
in the first week of life per 1000 live births [23].
Statistical analysis
Observations were censored at 15 January 2010, LTFU,
transfer or death, whichever occurred first. HIV trans-
mission, child deaths and LTFU of infants were treated
as time-to-event variables and were analyzed with
Kaplan-Meier (K-M) methods [24]. Factors associated
with LTFU of infants were recorded. Socio-demographic
(age, race, employment and marital status), clinical (any
illness during pregnancy, gestational age at first visit,
obstetric sepsis, preterm labour, maternal mortality)
immunological (CD4+ counts and viral loads) and bio-
logical (parity, mode of delivery, infant birth weight, sex
of infant and feeding modality) factors were assessed to
determine their association with LTFU of infants. Both
Table 1 Characteristics of pregnant HIV-infected women,
1 May 2008 to 31 May 2009, McCord Hospital
Maternal characteristics N* n % 95% Confidence
Intervals
Race 125
Black (South African) 119 95.2 89.8 - 98.2
Asian 4 3.2 0.9 - 8.0
White 1 0.8 0.0 - 4.4
Black (other African) 1 0.8 0.0 - 4.4
Parity 247
Primiparity 86 34.8 28.9 - 41.1




< 200 68 27.2 21.8 - 33.2
200 – 499 147 58.8 52.4 - 65.0




ART for life 128 49.6 43.4 - 55.9
PMTCT:
Zidovudine, lamivudine.
efavirenz from 28 weeks
85 32.9 27.2 - 39.0
Zidovudine from 28 weeks 40 15.5 11.3 - 20.5
sd-nevirapine + zidovudine
and lamivudine for 7 days
4 1.6 0.4 - 3.9




0-12 29 11.8 8.0 - 16.5
13-27 155 63.0 56.6 - 69.1




Yes 127 51.4 45.0 – 57.8
No 120 48.6 42.2 – 55.0
Pulmonary tuberculosis 127 12 9.4 5.0 -15.9
Mode of delivery 254
Emergency C/S 74 29.1 23.6 - 35.1
Booked C/S 89 35.0 29.2 - 41.3
NVD 91 35.8 29.9 - 42.1
Maternal mortality 256
No 255 99.6 97.8 – 100
Yes 1 0.4 0.0 - 2.2
N* The number of mothers across categories of maternal characteristics may
not add up to 258 due to missing data.
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ducted to identify important predictors. Cox Propor-
tional Hazards Regression analysis was used to retrieve
baseline survival function and to model multivariable
survival data. The Likelihood Ratio Test was used to
assess the fit of the model. For multiple regressions,
a backward elimination procedure used log-likelihood
criteria with p > 0.1 for removing variables and p < 0.05
for entering variables. Second and third-born infants
from multiple births (n = 7) were excluded from the ana-
lysis as it was assumed the factors associated with LTFU
would be the same for infants of multiple births.
All analyses were performed in Stata/IC version 11
(Statacorp, College Station, Texas).
Ethics
The study was approved by the University of KwaZulu-
Natal Biomedical Research Ethics Committee (reference
number BE160/08) and McCord Hospital Research
Ethics Committee. Individual patient consent was not
obtained for this retrospective study as patient contact
was not necessary. Moreover, no patient identifiers were
collected and data used for the study included only data
collected for standard care at McCord Hospital.
Results
In total, 272 HIV-infected mothers had deliveries be-
tween 1 May 2008 and 31 May 2009. Fourteen infants
were excluded from the study due to missing records
(n = 4), stillbirth deliveries (n = 4), duplicate entry (n = 1)
and not meeting the inclusion criteria (n = 5). There
were 258 deliveries resulting in 264 infants (251 single-
tons, five sets of twins and one set of triplets).
Median maternal age was 28.0 years (inter quartile
range (IQR): 25.0 to 33.0 years). Almost two-thirds of
mothers were employed and the majority were single.
The baseline median maternal CD4+ cell count was 308
cells/mm3 (IQR: 192 to 420 cells/mm3). The median
baseline viral load was 4320 copies/ml (IQR: 450 to 15
500 copies/ml). Twelve of 127 (9.4%) women with data
had pulmonary tuberculosis and were receiving treat-
ment (Table 1). There was only one maternal death
during the study period (Table 1). The cause of the
maternal death was reported as disseminated Kaposi’s
Sarcoma (data not shown).
Nearly half of the women (n = 128, 49.6%) included in
the study were on ART for life (Table 1). Of the 106
women for whom the date of ART initiation was avail-
able, 97 (91.5%) were initiated on ART for life in the
current pregnancy. The other 130 women (50.4%) were
prescribed ARV prophylaxis for PMTCT; 85 (32.9%)
were given interrupted triple therapy (zidovudine, lami-
vudine and efavirenz) from 28 weeks gestation until de-
livery, 40 (15.5%) were prescribed zidovudine from28 weeks, and four (1.6%) received sd-nevirapine at
delivery. Only one (0.4%) patient had sd-nevirapine
alone due to late attendance in labour. All ARV prophy-
laxis for PMTCT was followed by a seven day tail
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63.0%) attended their first antenatal visit at McCord
Hospital between 13 to 27 weeks of gestation.
The median length of infant follow-up at McCord
Hospital in this study was 9.1 months (IQR: 1.6 to 12.0
months) (Table 2). Of the 89 infants delivered through
elective caesarean sections, 44.9% (n = 40) of caesarean
sections were for women with viral loads above 1000
copies/ml at 36 weeks. The median birth weight was
3080 grams (IQR: 2780 to 3380 grams). There were 32
low birth weight infants (< 2500 grams) (12.8%; 95% CI:
8.9% to 17.6%). The median gestational age at birth was
38.0 weeks (IQR: 38.0 to 39.0 weeks). There were 189
infants born at term at or after 37 weeks (89.2%, 95%
CI: 84.2% to 93.0%). Most infants (n = 223, 98.7%)
received nevirapine and zidovudine as antiretroviral
prophylaxis following delivery.
Proportion of infants by feeding category at birth
The majority of the 264 infants were reported to be
exclusively formula-fed at birth (97.5%; 95% CI: 94.7% to
99.1%). The median duration of exclusive breastfeeding
in the five breastfed infants was 18.5 weeks (IQR: 13.0 to
24.0 weeks). Exclusively breastfeeding was slightly longer
than the median duration of exclusive formula feeding at
13.0 weeks (IQR: 6.0 to 14.0 weeks) (data not shown).
HIV transmission
At 6 weeks 220 (83.0%) infants returned for HIV testing
by PCR, and 6 (2.7%, 95% CI: 1.0% – 5.8%) were foundTable 2 Characteristics of HIV-exposed infants at McCord
Hospital, 1 May 2008 to 31 May 2009
Infant characteristics N* n % 95% Confidence
Interval
Observed length of follow-up
Median, months (IQR) 9.1 (1.6 - 12.0)
Sex 251
Male 122 48.6 42.3 - 55.0
Female 129 51.4 45.0 - 57.7
ARV prophylaxis at birth 226




Mean (median) 38.2 (38.0) 37.8 – 38.2
< 37 23 10.8 7.0 - 15.8
≥ 37 189 89.2 84.2 - 93.0
Birth weight (g) 250
Mean (median) 3052.3 (3080)
< 2500 32 12.8 8.9 – 17.6
≥ 2500 218 87.2 82.4 – 91.1
N** the number of infants across each category of characteristics do not add
up to 264 due to missing data.to be HIV positive. None of the 13 children who were
followed-up until 18 months of age were diagnosed as
HIV-infected (95% CI: 0.0% to 3.6%) (data not shown).
Mortality of infants from birth to five months
Among 264 infants in the cohort, four (1.5%) were
known to have died. The crude mortality rate at six
months was 15.2 per 1000 live births (95% CI: 4.1 to 38.3
per 1000 live births). There were eight perinatal deaths
(four stillbirths). The perinatal mortality rate was 30.3
per 1000 live births (95% CI: 13.2 to 58.8 per 1000 live
births). The neonatal mortality rate was 3.8 per 1000 live
births (n = 1; 95% CI: 0.1 to 21.2 per 1000 live births). In
Kaplan-Meier analyses, an estimated 1.7% of infants (95%
CI: 0.6% to 4.3%) would have died by six months of age.
The HIV-infection status and cause of death was un-
known for three of the infants who died. One infant who
died was diagnosed with meningitis at a tertiary level re-
ferral hospital. One infant who died was presumed HIV-
uninfected. Two deceased infants were exclusively for-
mula fed from birth; one infant was given formula and
solids from two months. No feeding data was available
for the remaining deceased infant (data not shown).
LTFU
Of the remaining 260 live-born infants, 105 (40.4%; 95%
CI: 34.4% to 46.6%) were LTFU, 155 infants (59.6%; 95%
CI: 53.4% to 65.6%) remained in care at McCord Hos-
pital beyond 28 weeks. Of these 155 infants, 13 infants
(8.4%, 95% CI: 4.5% - 13.9%) were followed-up until 18
months of age. Three infants (1.9%, 95% CI: 0.4% - 5.6%)
were transferred to other clinics. The period of greatest
LTFU was in the first week of life (n = 34) with an inci-
dence rate of 14.5 per 100 child-weeks (95% CI: 10.3 to
20.3 per 100 child-weeks). The LTFU rate declined
steadily after the first week of life. From one to ten
weeks, LTFU was 1.8 per 100 child-weeks (95% CI: 1.3
to 2.5 per 100 child-weeks). Sixteen infants were LTFU
between 11 and 19 weeks (incidence rate 1.0; 95% CI:
0.6 to 1.6 per 100 child-weeks). The LTFU rate between
20 to 28 weeks was 0.6 per 100 child-weeks (95% CI: 0.3
to 1.2 per 100 child-weeks). The LTFU rate was reduced
to 0.3 per 100 child-weeks (95% CI: 1.0 to 1.4 per 100
child-weeks) thereafter (data not shown).
Maternal socio-demographic, clinical and immunologic
factors associated with LTFU of infants
In multivariable analyses (excluding second and third
infants of multiple births), the 31 infants born to
mothers who had their first antenatal visit at or after
28 weeks were 2.3 times more likely to be LTFU, relative
to infants whose mothers booked in their first trimester
(95% CI: 1.0 to 5.1; p = 0.044) (Additional file 1: Table 3).
Maternal parity, age less than 30 years, being single and
Chetty et al. BMC Pediatrics 2012, 12:146 Page 6 of 8
http://www.biomedcentral.com/1471-2431/12/146unemployed, and having a CD4+ cell count 500 cells/
mm3 or more were not significantly associated with
LTFU due to lack of statistical power. The reasons for
LTFU of infants was missing in the majority of cases
(n = 83; 79.8%).
Discussion
In an urban South African setting, the integrated mother-
child postnatal clinic at McCord Hospital achieved good
outcomes in the first 13 months of its inception. These
outcomes included infant HIV testing of 83% and HIV
transmission risk of 2.7% at six weeks in returning HIV-
exposed infants whose mothers received PMTCT at
McCord Hospital. However, LTFU by six months was
substantial, limiting our ability to determine HIV-free
survival at 18 months.
In developed countries vertical transmission of HIV to
infants occurs in 1-2% of pregnancies in HIV infected
women, achieved through a combination of interven-
tions, including antiretroviral therapy regimens that
optimally suppress viral load, elective Caesarean section
and complete avoidance of breastfeeding [25-30]. In
developing countries the caesarean section proportion
ranges from 3% to 12.6% [11,12,31]. The high proportion
of caesarean sections at McCord Hospital may reflect
the ability of the women in this setting to choose the
best possible care for their infants and the hospital's cap-
acity to deliver a comprehensive package of interven-
tions to reduce the vertical transmission of HIV.
Although the rate of LTFU at McCord Hospital was
comparable to other PMTCT programmes in public set-
tings in sub-Saharan Africa [11,14,32-34], the high rate
of early dropout in our setting may in part be due to
women changing to service providers nearer to their
residences. The period of greatest attrition was in the
first week of life. This data may support the explanation
of mothers returning to clinics in closer proximity to
their homes. A similar finding was noted in a PMTCT
programme at a centralized hospital in Malawi [14]. The
authors suggested that the LTFU of mother-infant pairs
may have been due to women from rural areas returning
to their peripheral clinics following delivery [14]. The
revised South African PMTCT guidelines may improve
the follow-up of mothers and infants in this setting as
HIV-infected women attend for their own health, and
infants who are breastfed beyond six weeks require
repeated access to nevirapine until one week after cessa-
tion of breastfeeding.
Late antenatal presentation (28 weeks of gestation
or later) was a strong predictor of LTFU. There may be
several reasons for late antenatal clinic attendance at
McCord Hospital: women may have been minimizing
expenses related to antenatal care; lack of awareness of
the value of early antenatal care; or poor maternal healthseeking behaviours. These results highlight the import-
ance of identifying late antenatal attendees to determine
the risk factors which contribute to attrition following
delivery. Moreover, the fee-paying nature of the hospital
needs to be taken into account when assessing the attri-
tion of late antenatal attendees.
In prior studies, poor socio-demographic circum-
stances have been associated with patient attrition. In
Malawi HIV-exposed infants born to parents who were
less educated and in farming occupations were more
likely to be LTFU [11]. In our multivariable model, there
was no association between socio-demographic charac-
teristics and infant LTFU (maternal employment and
marital status). Since the parental level of education was
not routinely collected at the time this study was con-
ducted, the association with LTFU could not be assessed.
In the Ugandan study lack of understanding of the
importance of follow-up was noted as a reason for attri-
tion [12]. In Johannesburg, maternal unemployment,
geographical relocation and lack of paternal support
were noted as reasons for poor retention [10]. Maternal
education and support regarding the importance of
follow-up care for their own and their infants’ health
may improve patient retention and facilitate early diag-
nosis of infant morbidity and HIV transmission risk.
This study demonstrated that relative to infants of
HIV-infected women with CD4 + counts 200 cells/mm3
or less, infants born to mothers with CD4+ counts above
200 cells/mm3 were more likely to be lost to follow-up.
This finding was not statistically significant. Maternal
well-being may be a risk factor for poor retention in our
setting as mothers do not perceive themselves or their
infants to be at risk for disease. These mothers may
be less likely to seek health care. A similar correlation
between infant wellbeing and loss to follow-up was
shown in a study in rural Uganda, where infant illness
was a protective against loss to follow-up in the PMTCT
programme [12].
A key strength of this study was the ability to deter-
mine if patients were not returning for care. Clinic staff
at McCord Hospital routinely contacted patients if they
missed a scheduled appointment at the clinic, noting
reasons for the missed appointment and rescheduling
another. If these patients decided to attend other health
care facilities, they were not considered LTFU as the
reason for their non-attendance was known. Moreover,
routine monitoring allowed early detection of infants
requiring follow-up care.
A limitation of this study was the selection of the
study population. According to the selection criteria,
only infants whose mothers attended the PMTCT
programme at McCord Hospital, and/or were delivered
at McCord Hospital, and/or were brought back to
the hospital for follow-up care were included in the
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not brought back to McCord Hospital for further care
remained unknown. In addition, since the service was
not available, the study could not include a comparison
group of infants born to HIV-uninfected women from
McCord Hospital. Inclusion of this comparison group
would have made it possible to determine the back-
ground risk of HIV-exposed uninfected infants in terms
of loss to follow-up. Finally, errors in the routine mater-
nal and infant records and assignment of LTFU status
may have constituted information bias.
The results of this study may not be generalizable to
the HIV-exposed infant population in the public sector
in South Africa. Moreover, formula feeding was reported
as the predominant infant feeding modality. The impact
of feeding practices on infant mortality requires further
consideration. The results from this new integrated post-
natal mother and baby clinic at McCord Hospital pro-
vide important lessons for other PMTCT services in
developing settings. The attrition of HIV-exposed
infants, particularly those born to women who attended
antenatal services at McCord Hospital after 28 weeks
highlights the need to identify late antenatal attendees
for follow up care and to determine the HIV transmis-
sion risk and mortality of HIV-exposed infants.
Conclusions
As efforts are made to improve rates of early HIV detec-
tion at six weeks of age and subsequent provision of care
and treatment to HIV-exposed children in sub-Saharan
Africa, it is essential that we develop better understand-
ing of the determinants of retention and refine our strat-
egies for retaining children who are at the greatest risk
of morbidity and mortality in care. This preliminary
study assessed a new postnatal service with its accom-
panying problems, further study is recommended to
determine changes in the follow-up rates of infants.
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